// App-Quantinova.ai

BR09 : Lxr? Antagonism Mitigates Glucocorticoid-Induced Gluconeogenesis without Altering Immune Suppression

Researchers

Presenter

  • Ricky Tsai

Principal Investigators

  • Arturo Orellana

  • Carolyn L Cummins

Medical Centers

  • York University, Toronto, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Rheumatoid arthritis

  • Hyperglycemia

  • Inflammatory Arthritis

  • Asthma

  • Lupus

Biomarkers

  • Cortisol

  • Interleukin 1

Drug/Treatment

  • Glucocorticoid

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved